Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published November 3, 2023 | Published
Journal Article Open

Distinct use of super-enhancer elements controls cell type–specific CD25 transcription and function

Abstract

The IL-2 receptor α chain (IL-2Rα/CD25) is constitutively expressed on double-negative (DN2/DN3 thymocytes and regulatory T cells (T_(regs)) but induced by IL-2 on T and natural killer (NK) cells, with Il2ra expression regulated by a STAT5-dependent super-enhancer. We investigated CD25 regulation and function using a series of mice with deletions spanning STAT5-binding elements. Deleting the upstream super-enhancer region mainly affected constitutive CD25 expression on DN2/DN3 thymocytes and T_(regs), with these mice developing autoimmune alopecia, whereas deleting an intronic region decreased IL-2–induced CD25 on peripheral T and NK cells. Thus, distinct super-enhancer elements preferentially control constitutive versus inducible expression in a cell type–specific manner. The mediator-1 coactivator colocalized with specific STAT5-binding sites. Moreover, both upstream and intronic regions had extensive chromatin interactions, and deletion of either region altered the super-enhancer structure in mature T cells. These results demonstrate differential functions for distinct super-enhancer elements, thereby indicating previously unknown ways to manipulate CD25 expression in a cell type–specific fashion.

Copyright and License

© 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Acknowledgement

We thank N. Du for help with mast cell STAT5 ChIP-seq studies and K. Zhao for valuable discussions and critical comments. For ChIP-seq and RNA-seq analysis, DNA sequencing was performed in the NHLBI DNA Sequencing Core.

Funding

Funding: This work was supported by the Division of Intramural Research, National Heart, Lung, and Blood Institute (NHLBI) (W.J.L.) and NIH grants R01AI135200 and R01HD100039 (E.V.R.) and R01AI121426 and R01HL114093 (P.V.). B.S. was supported by a Cancer Research Institute-Irvington Postdoctoral Fellowship. S.G., K.S., and K.N. were supported by the Intramural Research Program of NIAMS and the NIAMS Office of Scientific Technology for flow cytometry and sequencing. B.Y. was supported by the SIRG Graduate Research Assistantships Award. M.K. was supported by the Purdue University Center for Cancer Research P30CA23168.

Contributions

Author contributions: R.S. and P.L. designed the project, performed experiments, interpreted data, and wrote the manuscript. V.C. and P.V. performed HiChIP experiments and analyzed the data. P.L, M.K., B.Y., and S.M.C. performed computational analysis. B.S. and E.V.R. performed the DN thymocyte in vitro experiments and ChIP-seq experiments, analyzed data, and wrote the manuscript. S.G, K.S., and K.N. performed the experiments on alopecia skin and analyzed the data. Z.-X.Y. performed the histological analysis of alopecia. C.L. and J.O. designed and constructed mouse deletion mutants. M.R., Y.E., E.E.W., E.C.K.W., J.O., M.G., and J.-X.L. contributed to in vitro cloning, animal experiments, and ChIP-seq experiments. W.J.L. supervised the project and wrote the manuscript.

Data Availability

For the RNA expression in control and Stat5a;Stat5b double knockout DN2 cells, the GSE accession number is GSE184845 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE184845). For the RNA-seq data from IL-2–induced CD8+ T cells (58), the GSE accession number is GSE143903. Other data can be viewed at https://nih.box.com/s/6bmco09put8ilgo1pgqd2xfdfzrrmff9, and raw data will be deposited in the GEO database before publication. Previously published data were accessed from GSE 110020, 148441, 110305, 218147, and 46662. All materials generated in this study will be made available upon request.

Conflict of Interest

The authors declare that they have no competing interests.

Files

sciimmunol.adi8217_sm.pdf
Files (15.7 MB)
Name Size Download all
md5:5abf285e8863405492193bb11b599f3a
33.6 kB Preview Download
md5:558dc48122409ce638574eb2e711dfa4
12.3 MB Preview Download
md5:ca5c9522f3ed08b42dedfd60458a5531
2.9 MB Preview Download
md5:edd5194de6c7f23d797f1e54a68b6fff
473.6 kB Preview Download
md5:5abf285e8863405492193bb11b599f3a
33.6 kB Preview Download

Additional details

Created:
November 13, 2023
Modified:
January 9, 2024